In our latest publication in PNAS we examined expression of miR-29a and miR-29b in 29 aggressive CLL samples, 33 indolent CLL samples and two normal CD19+ B-cell controls [15]. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.